According to a recent U.S. Food and Drug Administration (FDA) safety announcement, “use of the diabetes medication Actos for more than one year may be associated with an increased risk of bladder cancer.” The safety announcement explains that this risk information will soon be added to the “Warnings and Precautions section of the label for pioglitazone-containing medicines.” In addition, t